LEAH Labs on Wefunder

curing cancer in dogs

Raise to date: $464,988

Reporting Date: 03/01/2020

Key Stats

Minimum Raise

$100,000

Maximum Raise

$1,070,000

Likelihood of Max Unlikely
Start Date

09/05/2019

Stop Date

02/20/2020

Days Remaining

Closed

Security Type

SAFE

Investment Minimum

$100

Deal Type

Deal to Watch


Investment Summary

Status

Confirmed Closed

# of Investors

847

% of Minimum Raised

465%

% of Maximum Raised

43%

Dollars Per Day to Reach Max

N/A

DPD* Committed

$2,768

DPD* Category

$72

DPD* All Companies

$1,137

Kingscrowd Momentum

$464,988

Total Dollars Raised

Commitments

Weekly Commitments ($)
Aggregate Commitments ($)

SEC Filing Data from Kingscrowd

LEAH Labs, with a valuation cap of $6 million, is raising crowdfunding on WeFunder. The company is developing CAR T cell therapy to treat cancer in dogs. LEAH Labs has a patented technology that uses CRISPR to harness and reprogram T cells that find and kill cancer cells in dogs. LEAH Labs was founded by an experienced team including Stephen Carl Ekker, Jonathan Mochel and Saad Kenderian, and has raised more than $250,000 since its inception. The current crowdfunding round has a minimum raise of $100,000 and a maximum raise of $1,070,000, and the funds will be used towards research & development, business development, and maintaining and hiring talent. LEAH Labs is backed by Y Combinator and is led by PhD experts in gene editing, cell therapy, and veterinary oncology.

Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add LEAH Labs on Wefunder
Follow company
Follow LEAH Labs on Wefunder
INVEST NOW

Get access to the first and only premium analytics and rating platform that enables informed startup investments.

Become an Informed Investor